|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sung JJ, Lau JY, Goh KL and Leung WK; Asia
Pacific Working Group on Colorectal Cancer, : Increasing incidence
of colorectal cancer in asia: Implications for screening. Lancet
Oncol. 6:871–876. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vatandoust S, Price TJ and Karapetis CS:
Colorectal cancer: Metastases to a single organ. World J
Gastroenterol. 21:11767–11776. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lutgendorf SK, Sood AK and Antoni MH: Host
factors and cancer progression: Biobehavioral signaling pathways
and interventions. J Clin Oncol. 28:4094–4099. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Worster B and Holmes S: The preoperative
experience of patients undergoing surgery for colorectal cancer: A
phenomenological study. Eur J Oncol Nurs. 12:418–424. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Alberts D, Lluria-Prevatt M, Kha S and
Weihs K: Supportive Cancer Care. 1st. Springer International
Publishing; Switzerland: pp. 45–76. 2016, PubMed/NCBI
|
|
8
|
Chubak J, Boudreau DM, Rulyak SJ and
Mandelson MT: Colorectal cancer risk in relation to antidepressant
medication use. Int J Cancer. 128:227–232. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Koh SJ, Kim JM, Kim LK, Kim N, Jung HC,
Song IS and Kim JS: Fluoxetine inhibits NF-κB signaling in
intestinal epithelial cells and ameliorates experimental colitis
and colitis-associated colon cancer in mice. Am J Physiol
Gastrointest Liver Physiol. 301:G9–G19. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kannen V, Garcia SB, Silva WA Jr, Dasser
M, Mönch R, Alho EJ, Heinsen H, Scholz CJ, Friedrich M, Heinze KG,
et al: Oncostatic effects of fluoxetine in experimental colon
cancer models. Cell Signal. 27:1781–1788. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kristensen AS, Andersen J, Jørgensen TN,
Sørensen L, Eriksen J, Loland CJ, Strømgaard K and Gether U: SLC6
neurotransmitter transporters: Structure, function and regulation.
Pharmacol Rev. 63:585–640. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mandela P and Ordway GA: The
norepinephrine transporter and its regulation. J Neurochem.
97:310–313. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pramod AB, Foster J, Carvelli L and Henry
LK: SLC6 transporters: Structure, function, regulation, disease
association and therapeutics. Mol Aspects Med. 34:197–219. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zahniser NR and Doolen S: Chronic and
acute regulation of Na+/Cl− dependent
neurotransmitter transporters: Drugs, substrates, presynaptic
receptors, and signaling systems. Pharmacol Ther. 92:21–55. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Höpfner M, Sutter AP, Huether A,
Ahnert-Hilger G and Scherübl H: A novel approach in the treatment
of neuroendocrine gastrointestinal tumors: Additive
antiproliferative effects of interferon-gamma and
meta-iodobenzylguanidine. BMC Cancer. 4:232004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hahn MK and Blakely RD: The functional
impact of SLC6 transporter genetic variation. Annu Rev Pharmacol
Toxicol. 47:401–441. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Matthay KK, George RE and Yu AL: Promising
therapeutic targets in neuroblastoma. Clin Cancer Res.
18:2740–2753. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cavallaro U and Christofori G: Cell
adhesion and signaling by cadherins and Ig-CAMs in cancer. Nat Rev
Cancer. 4:118–132. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Weiss JV, Klein-Scory S, Kübler S,
Reinacher-Schick A, Stricker I, Schmiegel W and Schwarte-Waldhoff
I: Soluble E-cadherin as a serum biomarker candidate: Elevated
levels in patients with late-stage colorectal carcinoma and FAP.
Int J Cancer. 128:1384–1392. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Okugawa Y, Toiyama Y, Inoue Y, Iwata T,
Fujikawa H, Saigusa S, Konishi N, Tanaka K, Uchida K and Kusunoki
M: Clinical significance of serum soluble E-cadherin in colorectal
carcinoma. J Surg Res. 175:e67–e73. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hu YY, Zheng MH, Zhang R, Liang YM and Han
H: Notch signaling pathway and cancer metastasis. Adv Exp Med Biol.
727:186–198. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen J, Imanaka N, Chen J and Griffin JD:
Hypoxia potentiates notch signaling in breast cancer leading to
decreased E-cadherin expression and increased cell migration and
invasion. Br J Cancer. 102:351–360. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang XQ, Zhang W, Lui EL, Zhu Y, Lu P, Yu
X, Sun J, Yang S, Poon RT and Fan ST: Notch1-Snail1-E-cadherin
pathway in metastastic hepatocellular carcinoma. Int J Cancer.
131:E163–E172. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yuan R, Ke J, Sun L, He Z, Zou Y, He X,
Chen Y, Wu X, Cai Z, Wang L, et al: HES1 promotes metastasis and
predicts poor survival in patients with colorectal cancer. Clin Exp
Metastasis. 32:169–179. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hu YF, Caron MG and Sieber-Blum M:
Norepinephrine transport-mediated gene expression in noradrenergic
neurogenesis. BMC Genomics. 10:1512009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cancer Genome Atlas Network: Comprehensive
molecular characterization of human colon and rectal cancer.
Nature. 487:330–337. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang MY, Liu XX, Li H, Li R, Liu X and Qu
YQ: Elevates mRNA levels of AURKA, CDC20 and TPX2 are associated
with poor prognosis of smoking related lung adenocarcinoma using
bioinformatics analysis. Int J Med Sci. 15:1676–1685. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hou N, Zhang X, Zhao LY, Zhao XG, Li ZF,
Song TS and Huang C: A novel chronic stress-induced shift in the
Th1 to Th2 response promotes colon cancer growth. Biochem Biophys
Res Commun. 439:471–476. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhou X, Zhao F, Wang ZN, Song YX, Chang H,
Chiang Y and Xu HM: Altered expression of miR-152 and miR-148a in
ovarian cancer is related to cell proliferation. Oncol Rep.
27:447–454. 2012.PubMed/NCBI
|
|
30
|
Ouyang W, Ren L, Liu G, Chi X and Wei H:
LncRNA MIR4435-2HG predicts poor prognosis in patients with
colorectal cancer. Peer J. 7:e66832019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tania M, Khan MA and Fu J: Epithelial to
mesenchymal transition inducing transcription factors and
metastatic cancer. Tumor Biol. 35:7335–7342. 2014. View Article : Google Scholar
|
|
32
|
Pandit-Taskar N and Modak S:
Norepinephrine transporter as a target for imaging and therapy. J
Nucl Med. 58 (Suppl 2):39S–53S. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tang J, Li Z, Lu L and Cho CH:
β-Adrenergic system, a backstage manipulator regulating tumour
progression and drug target in cancer therapy. Semin Cancer Biol.
23:533–542. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kannen V, Hintzche H, Zanette DL, Silva WA
Jr, Garcia SB, Waaga-Gasser AM and Stopper H: Antiproliferative
effects of fluoxetine on colon cancer cells and in a colonic
carcinogen mouse model. PLoS One. 7:e500432012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Stopper H, Garcia SB, Waaga-Gasser AM and
Kannen V: Antidepressant fluoxetine and its potential against colon
tumors. World J Gastrointest Oncol. 6:11–21. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Leong KG, Niessen K, Kulic I, Raouf A,
Eaves C, Pollet I and Karsan A: Jagged1-mediated notch activation
induces epithelial- to-mesenchymal transition through Slug-induced
repression of E-cadherin. J Exp Med. 204:2935–2948. 2007.
View Article : Google Scholar : PubMed/NCBI
|
